Birmingham Injury Blog

http://www.alabamaproductinjurylawyer.com/2009/08/fda_probes_orlistat_alli_and_x.htmlThe Alabama Product Injury Lawyer Blog has posted an entry about a new drug warning from the FDA. The FDA has issued an "early communication" warning for weight loss drugs containing Orlistat. So far, the agency says it has received 32 reports of "serious liver injury," including 6 instances of complete liver failure in patients who had taken the drug. Orlistat is in the over the counter weight loss drug Alli and the prescription drug Xenical.

GlaxoSmithKline, which manufactures Alli, the OTC version of this drug, insists "there is no evidence that Alli causes liver damage". The company went on to indicate the people who are overweight or obese are predisposed to liver problems.

The FDA released a statement saying that there is no "definite association" between Orlistat and liver injury, but the data is being reviewed.